Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
EXERCISING OY1 THE HOURLY RATE IS CHANGING FROM $49.58 PER HOUR TO $38.91 PER HOUR BEGINNING ON JANUARY 1, 2023. is a federal award for 250-Network Contract Office 10 (36C250) held by Ino Therapeutics LLC. Estimated value $332K ($158K obligated). Current period of performance ends Apr 26, 2026 (potential Apr 26, 2027). Last award drew 1 bidder. Place of performance: HAZELWOOD MO.
EXERCISING OY1 THE HOURLY RATE IS CHANGING FROM $49.58 PER HOUR TO $38.91 PER HOUR BEGINNING ON JANUARY 1, 2023.
Recompete timing
PublicCurrent PoP ended Apr 26, 2026 (117 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordIno Therapeutics LLC — $2.5M obligated across 84 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25022F0432?
36C25022F0432 (Exercising oy1 the HOURLY RATE IS) is a 250-Network Contract Office 10 (36C250) award with a potential value of $332K, currently held by Ino Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C250-22-F-0432?
36C250-22-F-0432 is the dashed form of PIID 36C25022F0432 (Exercising oy1 the HOURLY RATE IS), held by Ino Therapeutics LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25022F0432?
250-Network Contract Office 10 (36C250) awarded 36C25022F0432 to Ino Therapeutics LLC (potential $332K).
Who is the incumbent on 36C25022F0432?
Ino Therapeutics LLC is the incumbent with $2.5M across 84 related awards in SCOUT’s public footprint. The current period of performance ends Apr 26, 2026.
When does Ino Therapeutics LLC’s 36C25022F0432 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 26, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
